3. Lara PN Jr, Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005;23(36):9282-9289.
4. TUFTS Center for the Study of Drug Development. Impact Report. Oncology Drugs Get Faster Approvals than Non-Oncology Drugs in U.S. Sept/Oct 2012;14(5).
Continue Reading
5. Eisenberg C. Drugmakers Mine Data for Trial Patients. Bloomberg Businessweek Magazine. November 2011. http://www.businessweek.com/magazine/drugmakers-mine-data-for-trial-patients-11032011.html. Accessed October 4, 2012.
6. Mills EJ, Seely D, Rachlis B, et al. Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol. 2006;7(2):141-148.
7. Cancer.gov. Cancer Clinical Trials – The In-Depth Program. http://www.cancer.gov/clinicaltrials/learningabout/in-depth-program/page7#BarriersHCP. Accessed October 4, 2012.
8. Frank G. Current Challenges in Clinical Trial Patient Recruitment and Enrollment. SoCRASource. 2004:30-38. http://www.socra.org/pdf/200402_Current_Challenges_Recruitment_Enrollment.pdf. Accessed October 4, 2012.
9. Mack A, Nass S. National Cancer Policy Forum; Institute of Medicine. An American Society of Clinical Oncology and Institute of Medicine Workshop; 2011.
10. Center for Information & Study on Clinical Research Participation (CISCRP). Clinical Trials Facts & Figures. http://www.ciscrp.org/professional/facts_pat.html. Accessed October 4, 2012.
11. Virani S, Burke L, Remick SC, Abraham J. Barriers to recruitment of rural patients in cancer clinical trials. J Oncol Pract. 2011;3(7):172-177.
12. Gelijns AC, Gabriel SE. Looking beyond translation–integrating clinical research with medical practice. N Engl J Med. 2012;366(18):1659-1661.
